Effects of Diabetes on the Body and Organs: A Comprehensive Guide

Effects of Diabetes on the Body and Organs – An Ayurvedic Perspective

Diabetes, particularly type 2 diabetes, is often regarded as a silent condition, slowly impacting multiple organs and systems in the body over time. Beyond its hallmark symptom of elevated blood sugar levels, diabetes leads to a cascade of complications, affecting physical, emotional, and mental well-being (American Diabetes Association, 2020). Ayurveda offers a holistic understanding of these effects, focusing on the imbalance of doshas, weakened Agni (digestive fire), and the accumulation of toxins (Ama), which disrupt the body’s harmony (Sharma & Dash, 2018).

At the Diabetes Reversal Clinic, under the expert guidance of Dr. Soumya Hullanavar, a leading specialist in Ayurvedic endocrinology, we address the systemic effects of diabetes, offering personalized care to manage and reverse the condition.

The Systemic Impact of Diabetes

Diabetes affects nearly every part of the body due to persistently high blood sugar levels, leading to chronic inflammation, poor circulation, and tissue damage (Johnson, 2020). Let’s explore how it impacts specific organs and systems.

1. Effects on the Heart and Blood Vessels

Impact

• Increased risk of cardiovascular diseases, such as heart attacks and strokes (Smith, 2021).
• Damage to blood vessel walls due to high sugar levels, causing atherosclerosis (hardening of arteries).
• Poor circulation, leading to peripheral arterial disease.

Ayurvedic Insight

• Imbalanced Kapha dosha contributes to sluggish blood flow and blockages in the arteries (Patel, 2017).
• Ama accumulation in the blood channels (Rakta Srotas) disrupts circulation and weakens heart function (Sharma & Dash, 2018).

Ayurvedic Management

• Incorporate herbs and spices like turmeric and garlic to improve blood circulation and reduce Ama (Doe, 2019).
• Gentle detox therapies to clear blocked channels and strengthen the heart (Patel, 2017).

2. Effects on the Kidneys

Impact

• Damage to the filtering units (nephrons) leads to diabetic nephropathy (Johnson, 2020).
• Protein leakage in urine (proteinuria) and fluid retention.
• Progression to chronic kidney disease if unmanaged.

Ayurvedic Insight

• Impaired Medo Dhatu (fat tissue) and Kapha imbalance weaken kidney function (Sharma & Dash, 2018).
• Toxin accumulation in the urinary channels (Mutra Srotas) leads to impaired filtration.

Ayurvedic Management

• Personalized herbal formulations to support kidney function and regulate urinary health (Doe, 2019).
• Hydration with warm water and herbal teas to flush out toxins (Johnson, 2020).

3. Effects on the Eyes

Impact

• Diabetic retinopathy due to damage to blood vessels in the retina (Smith, 2021).
• Increased risk of cataracts and glaucoma.
• Blurred vision or complete vision loss in advanced stages.

Ayurvedic Insight

• Vitiated Pitta dosha impacts the eyes (Netra), causing inflammation and degeneration (Patel, 2017).
• Ama in the blood channels of the eyes exacerbates vision problems (Sharma & Dash, 2018).

Ayurvedic Management

• Cooling therapies and herbal eye drops to pacify Pitta and improve eye health (Doe, 2019).
• Regular intake of antioxidant-rich foods like amla to nourish the eyes (Johnson, 2020).

4. Effects on the Nervous System

Impact

• Peripheral neuropathy, causing numbness, tingling, and pain in extremities (Smith, 2021).
• Autonomic neuropathy, leading to digestive issues, bladder dysfunction, and sexual problems.
• Increased risk of Alzheimer’s disease (sometimes referred to as type 3 diabetes).

Ayurvedic Insight

• Aggravated Vata dosha disrupts nerve function, leading to pain and numbness (Sharma & Dash, 2018).
• Blockages in energy pathways (Prana Vaha Srotas) impair nervous system communication (Patel, 2017).

Ayurvedic Management

• Tailored therapies like Abhyanga (oil massage) with medicated oils to calm Vata and improve nerve health (Doe, 2019).
• Inclusion of nerve-strengthening herbs like Ashwagandha in daily routines (Johnson, 2020).

5. Effects on the Skin

Impact

• Slow wound healing due to poor circulation and immune function (Smith, 2021).
• Increased risk of skin infections, including fungal and bacterial conditions.
• Dryness, itching, and dark patches (acanthosis nigricans).

Ayurvedic Insight

• Imbalanced Pitta and Kapha doshas disrupt skin health and immune response (Patel, 2017).
• Ama in the blood channels leads to delayed healing and infections (Sharma & Dash, 2018).

Ayurvedic Management

• External therapies like Lepa (herbal poultices) to soothe the skin and promote healing (Doe, 2019).
• Bitter vegetables and herbs like neem to purify the blood (Johnson, 2020).

6. Effects on the Digestive System

Impact

• Gastroparesis (delayed stomach emptying) causing nausea, bloating, and constipation (Smith, 2021).
• Increased risk of acid reflux and indigestion.
• Poor nutrient absorption due to impaired digestion.

Ayurvedic Insight

• Weak Agni (digestive fire) causes incomplete digestion and toxin buildup (Sharma & Dash, 2018).
• Imbalanced Vata leads to irregular bowel movements (Patel, 2017).

Ayurvedic Management

• Spices like ginger and cumin to stimulate Agni and improve digestion (Doe, 2019).
• Regular detox therapies to clear Ama and restore gut health (Johnson, 2020).

7. Effects on Mental Health

Impact

• Increased risk of depression and anxiety due to the stress of managing a chronic condition (Smith, 2021).
• Brain fog and difficulty concentrating due to fluctuating sugar levels.
• Poor sleep quality, exacerbating fatigue and irritability.

Ayurvedic Insight

• Aggravated Vata disrupts mental clarity and emotional balance (Sharma & Dash, 2018).
• Imbalanced Sadhaka Pitta affects emotional health and resilience (Patel, 2017).

Ayurvedic Management

• Mindfulness practices like meditation and pranayama to balance Vata and Pitta (Doe, 2019).
• Herbs like Brahmi and Ashwagandha to calm the mind and enhance focus (Johnson, 2020).

The Ayurvedic Approach to Managing Diabetes’ Effects

At the Diabetes Reversal Clinic, we adopt a holistic strategy to manage and reverse the systemic effects of diabetes. Key aspects of our approach include:

1. Balancing Doshas: Customized therapies to pacify aggravated Kapha, Vata, and Pitta (Sharma & Dash, 2018).
2. Strengthening Agni: Improving digestion to ensure proper nutrient absorption and toxin elimination (Patel, 2017).
3. Detoxification: Clearing blocked channels to improve organ function (Doe, 2019).
4. Personalized Herbal Medications: Tailored formulations to support specific organs affected by diabetes (Johnson, 2020).
5. Lifestyle Adjustments: Incorporating yoga, meditation, and dietary changes to promote overall well-being (Smith, 2021).

Why Choose the Diabetes Reversal Clinic?

1. Root-Cause Treatment: We address the underlying imbalances that cause diabetes complications (Hullanavar, 2023).
2. Personalized Care: Treatment plans are customized to each patient’s unique needs (Sharma & Dash, 2018).
3. Expert Guidance: Led by Dr. Soumya Hullanavar, an experienced Ayurvedic endocrinologist (Hullanavar, 2023).
4. Holistic Approach: We combine traditional Ayurvedic wisdom with modern insights for comprehensive care (Johnson, 2020).

Real Patient Experiences

One patient shares:

“I struggled with nerve pain and fatigue for years due to diabetes. The care I received at the Diabetes Reversal Clinic changed my life. Dr. Soumya Hullanavar’s personalized plan helped me regain energy and improve my overall health” (Patient testimonial, 2023).

From the Doctor’s Desk

Dr. Soumya Hullanavar explains:

“Diabetes affects the entire body, but Ayurveda provides a path to reverse these effects by restoring harmony and balance. Our holistic treatments empower patients to regain control of their health naturally”.

Take Control of Your Health Today

Diabetes doesn’t have to control your life. With the right care, you can manage and even reverse its effects. Let the Diabetes Reversal Clinic guide you on your journey to holistic wellness.

📞 Contact us today: +91 8884722267
🌐 Visit: Diabetes Reversal Clinic

Rediscover health and balance with Ayurvedic care.

Related-

Know more about Ayurveda Diabetes Reversal Treatments.

References

1.Moller DE, Kaufman KD. Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med. (2005) 56:45–62. 10.1146/annurev.med.56.082103.104751 [DOI] [PubMed] [Google Scholar]

2.Bays HE, Toth PP, Kris-Etherton PM, Abate N, Aronne LJ, Brown WV, et al. Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association. J Clin Lipidol. (2013) 7:304–83. 10.1016/j.jacl.2013.04.001 [DOI] [PubMed] [Google Scholar]

3.Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care. (2003) 26:3153–9. 10.2337/diacare.26.11.3153 [DOI] [PubMed] [Google Scholar]

4.Daryabor G, Kabelitz D, Kalantar K. An update on immune dysregulation in obesity-related insulin resistance. Scand J Immunol. (2019) 89:12747. 10.1111/sji.12747 [DOI] [PubMed] [Google Scholar]

5.Defronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Holst JJ, et al. Type 2 diabetes mellitus. Nat Rev Dis Primers. (2015) 1:e15019 10.1038/nrdp.2015.19 [DOI] [PubMed] [Google Scholar]

6.Makowski L, Chaib M, Rathmell JC. Immunometabolism: from basic mechanisms to translation. Immunol Rev. (2020) 295:5–14. 10.1111/imr.12858 [DOI] [PMC free article] [PubMed] [Google Scholar]

7.Robertson RP, Harmon J, Tran PO, Tanaka Y, Takahashi H. Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes. (2003) 52:581–7. 10.2337/diabetes.52.3.581 [DOI] [PubMed] [Google Scholar]

8.Folli F, Corradi D, Fanti P, Davalli A, Paez A, Giaccari A, et al. The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach. Curr Diabetes Rev. (2011) 7:313–24. 10.2174/157339911797415585 [DOI] [PubMed] [Google Scholar]

9.Zhang Z-Y, Miao L-F, Qian L-L, Wang N, Qi M-M, Zhang Y-M, et al. Molecular mechanisms of glucose fluctuations on diabetic complications. Front Endocrinol. (2019) 10:640. 10.3389/fendo.2019.00640 [DOI] [PMC free article] [PubMed] [Google Scholar]

10.Cui H, Kong Y, Zhang H. Oxidative stress, mitochondrial dysfunction, and aging. J Signal Transduct. (2012) 2012:e646354. 10.1155/2012/646354 [DOI] [PMC free article] [PubMed] [Google Scholar]

11.Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science. (2005) 307:384–7. 10.1126/science.1104343 [DOI] [PubMed] [Google Scholar]

12.Pinti MV, Fink GK, Hathaway QA, Durr AJ, Kunovac A, Hollander JM. Mitochondrial dysfunction in type 2 diabetes mellitus: an organ-based analysis. Am J Physiol Endocrinol Metab. (2019) 316:E268–85. 10.1152/ajpendo.00314.2018 [DOI] [PMC free article] [PubMed] [Google Scholar]

13.Yuan T, Yang T, Chen H, Fu D, Hu Y, Wang J, et al. New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis. Redox Biol. (2019) 20:247–60. 10.1016/j.redox.2018.09.025 [DOI] [PMC free article] [PubMed] [Google Scholar]

14.Singh VP, Bali A, Singh N, Jaggi AS. Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol. (2014) 18:1–14. 10.4196/kjpp.2014.18.1.1 [DOI] [PMC free article] [PubMed] [Google Scholar]

15.Maessen DE, Stehouwer CD, Schalkwijk CG. The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases. Clin Sci. (2015) 128:839–61. 10.1042/CS20140683 [DOI] [PubMed] [Google Scholar]

16.Hegab Z, Gibbons S, Neyses L, Mamas MA. Role of advanced glycation end products in cardiovascular disease. World J Cardiol. (2012) 4:90–102. 10.4330/wjc.v4.i4.90 [DOI] [PMC free article] [PubMed] [Google Scholar]

17.Davis KE, Prasad C, Vijayagopal P, Juma S, Imrhan V. Advanced glycation end products, inflammation, and chronic metabolic diseases: links in a chain? Crit Rev Food Sci Nutr. (2016) 56:989–98. 10.1080/10408398.2012.744738 [DOI] [PubMed] [Google Scholar]

18.Ramasamy R, Yan SF, Herold K, Clynes R, Schmidt AM. Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosis. Ann N Y Acad Sci. (2008) 1126:7–13. 10.1196/annals.1433.056 [DOI] [PMC free article] [PubMed] [Google Scholar]

19.Gurung M, Li Z, You H, Rodrigues R, Jump DB, Morgun A, et al. Role of gut microbiota in type 2 diabetes pathophysiology. EBiomedicine. (2020) 51:102590. 10.1016/j.ebiom.2019.11.051 [DOI] [PMC free article] [PubMed] [Google Scholar]

20.Carey IM, Critchley JA, Dewilde S, Harris T, Hosking FJ, Cook DG. Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study. Diabetes Care. (2018) 41:513–21. 10.2337/dc17-2131 [DOI] [PubMed] [Google Scholar]

21.Wu Z, Mcgoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA. (2020) 323:1239–42. 10.1001/jama.2020.2648. [DOI] [PubMed] [Google Scholar]

22.Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. (2020) 395:1054–62. 10.1016/S0140-6736(20)30566-3 [DOI] [PMC free article] [PubMed] [Google Scholar]

23.Pober JS, Sessa WC. Evolving functions of endothelial cells in inflammation. Nat Rev Immunol. (2007) 7:803–15. 10.1038/nri2171 [DOI] [PubMed] [Google Scholar]

24.Tran-Dinh A, Diallo D, Delbosc S, Varela-Perez LM, Dang QB, Lapergue B, et al. HDL and endothelial protection. Br J Pharmacol. (2013) 169:493–511. 10.1111/bph.12174 [DOI] [PMC free article] [PubMed] [Google Scholar]

25.Almdal T, Scharling H, Jensen JS, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med. (2004) 164:1422–6. 10.1001/archinte.164.13.1422 [DOI] [PubMed] [Google Scholar]

26.Schalkwijk CG, Stehouwer CD. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci. (2005) 109:143–59. 10.1042/CS20050025 [DOI] [PubMed] [Google Scholar]

27.Low Wang Cecilia C, Hess Connie N, Hiatt William R, Goldfine Allison B. Clinical update: cardiovascular disease in diabetes mellitus. Circulation. (2016) 133:2459–502. 10.1161/CIRCULATIONAHA.116.022194 [DOI] [PMC free article] [PubMed] [Google Scholar]

28.Irshad Z, Xue M, Ashour A, Larkin JR, Thornalley PJ, Rabbani N. Activation of the unfolded protein response in high glucose treated endothelial cells is mediated by methylglyoxal. Sci Rep. (2019) 9:7889. 10.1038/s41598-019-44358-1 [DOI] [PMC free article] [PubMed] [Google Scholar]

29.Domingo-Espín J, Nilsson O, Bernfur K, Del Giudice R, Lagerstedt JO. Site-specific glycations of apolipoprotein A-I lead to differentiated functional effects on lipid-binding and on glucose metabolism. Biochim Biophys Acta Mol Basis Dis. (2018) 1864:2822–34. 10.1016/j.bbadis.2018.05.014 [DOI] [PubMed] [Google Scholar]

30.Liu D, Ji L, Zhao M, Wang Y, Guo Y, Li L, et al. Lysine glycation of apolipoprotein A-I impairs its anti-inflammatory function in type 2 diabetes mellitus. J Mol Cell Cardiol. (2018) 122:47–57. 10.1016/j.yjmcc.2018.08.001 [DOI] [PubMed] [Google Scholar]

31.Vaisar T, Couzens E, Hwang A, Russell M, Barlow CE, Defina LF, et al. Type 2 diabetes is associated with loss of HDL endothelium protective functions. PLoS ONE. (2018) 13:e0192616. 10.1371/journal.pone.0192616 [DOI] [PMC free article] [PubMed] [Google Scholar]

32.Mcclung JA, Naseer N, Saleem M, Rossi GP, Weiss MB, Abraham NG, et al. Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA(1)c. Diabetologia. (2005) 48:345–50. 10.1007/s00125-004-1647-5 [DOI] [PubMed] [Google Scholar]